CollPlant Biotechnologies Ltd. (CLGN)
3.51
-0.46
(-11.59%)
USD |
NASDAQ |
Oct 09, 16:00
3.61
+0.10
(+2.85%)
After-Hours: 20:00
CollPlant Biotechnologies Debt to Equity Ratio : 0.9032 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.9032 |
| March 31, 2026 | 0.5422 |
| December 31, 2025 | 0.468 |
| September 30, 2025 | 0.316 |
| June 30, 2025 | 0.2421 |
| March 31, 2025 | 0.2293 |
| December 31, 2024 | 0.2288 |
| September 30, 2024 | 0.1923 |
| June 30, 2024 | 0.1633 |
| March 31, 2024 | 0.1235 |
| December 31, 2023 | 0.1115 |
| September 30, 2023 | 0.0956 |
| June 30, 2023 | 0.0928 |
| March 31, 2023 | 0.1163 |
| December 31, 2022 | 0.0902 |
| September 30, 2022 | 0.0811 |
| June 30, 2022 | 0.0765 |
| March 31, 2022 | 0.0794 |
| December 31, 2021 | 0.08 |
| September 30, 2021 | 0.0687 |
| June 30, 2021 | 0.0668 |
| March 31, 2021 | 0.0644 |
| December 31, 2020 | 0.7568 |
| September 30, 2020 | 0.4807 |
| June 30, 2020 | 0.5898 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | -6.599 |
| June 30, 2019 | 1.993 |
| March 31, 2019 | 1.130 |
| December 31, 2018 | 0.0094 |
| September 30, 2018 | 0.0141 |
| June 30, 2018 | 0.0162 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 1.392 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Anika Therapeutics, Inc. | 0.1839 |
| Perspective Therapeutics, Inc. | 0.0122 |
| MiMedx Group, Inc. | 0.0797 |
| Regentis Biomaterials Ltd. | -- |
| Xylo Technologies Ltd. | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 7.197M |
| Total Liabilities (Quarterly) | 4.252M |
| Shareholders Equity (Quarterly) | 2.945M |
| Current Ratio | 1.567 |
| Net Debt Paydown Yield | 0.73% |